California-Based Biotech Rallies Strongly Following $558.4M Divestiture
03 Décembre 2024 - 8:20PM
AllPennyStocks.com
A California-based biotech company found a
tremendous amount of success on Tuesday following the company
announcing an agreement to divest its Udenyca franchise for
$558.4...
To read the full story on AllPennyStocks.com, click
here.
Coherus BioSciences (NASDAQ:CHRS)
Graphique Historique de l'Action
De Nov 2024 à Déc 2024
Coherus BioSciences (NASDAQ:CHRS)
Graphique Historique de l'Action
De Déc 2023 à Déc 2024
